Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

BBOTBBOT
4 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in BRIDGEBIO ONCOLOGY THERAPEUT

NORTHERN TRUST CORP holds 186,482 shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $1.4M as of 2026-Q2. The position was increased (+82.4% shares). BBOT represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$1.4M

Current Shares

186,482

Total Value Change

+$309,811

Total Shares Change

+90,525

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
186,482
+82.4%
$1.4M0.0%$7.62
39
2026-Q1
Increased
102,258
+76.2%
$915,2090.0%$9.74
38
2025-Q4
Decreased
58,034
-39.5%
$726,5860.0%$12.37
0
2025-Q3
New
95,957
-
$1.1M0.0%$11.47
35

Other major holders of BBOT: WELLINGTON MANAGEMENT GROUP LLP, Alphabet Inc., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used